Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

Researchers 3D-print heart components using collagen

Researchers at Carnegie Mellon University’s College of Engineering have devised a way to 3D bioprint tissue scaffolds out of collagen, putting them one step closer to the goal of printing a full-sized, functional human heart.

Thumbnail

Are patients undergoing unnecessary gated calcium CT imaging?

“Knowledge of CAC on a prior chest CT may eliminate the need for a subsequent dedicated gated calcium score CT, leading to earlier diagnosis and management of cardiovascular disease as well as decreasing radiation exposure and health care costs,” wrote authors of a recent study.

CT CAC associated with long-term mortality in young adults

A high coronary artery calcium (CAC) score was linked to an increased risk for cardiovascular disease (CVD) and mortality in patients between 30 and 49 years old, researchers of a new study published in JAMA Network Open found.

Thumbnail

Medtronic, Viz.ai partner to improve LVO stroke detection

Medtronic and Viz.ai, an AI-driven tech company, have joined forces to promote the adoption of imaging software that could drastically cut the time it takes physicians to identify suspected large vessel occlusion.

Thumbnail

Chemicals in plastic medical devices could interfere with cardiac electrophysiology

Heart patients exposed to phthalates—a group of chemicals used as plasticizers in the manufacture of plastic medical products—during invasive procedures may be at risk for serious electrophysiological abnormalities, according to a new study.

Thumbnail

Gadobutrol 1st-ever contrast agent approved for use in cardiac MR

Gadobutrol, sold by Bayer under the brand name Gadavist, became the first FDA-approved contrast agent for use in cardiac magnetic resonance imaging on July 15.

Thumbnail

Outsourcing Is In: Developing & Integrating Cath Lab Best Practices & Standardization

Sponsored by Terumo

Sometimes a move in the right direction starts with a good hard look in the rearview mirror, then breaking it off to start anew with greater wisdom.

MEDNAX Radiology Solutions Chief Medical Officer Presents at SCCT 2019 on New National Cardiac Centers of Excellence Program

MEDNAX, Inc. (NYSE: MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, announced that Chief Medical Officer, Ricardo C. Cury, MD, FSCCT, will present at the 14th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) at the Baltimore Marriott Waterfront in Baltimore, Md. today.